Caprock Group’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$756K Sell
2,832
-894
-24% -$242K 0.02% 622
2025
Q4
$935K Sell
3,726
-31
-0.8% -$8.23K 0.02% 621
2025
Q3
$1.05M Buy
+3,757
New +$1.01M 0.03% 558
2025
Q1
$510K Sell
2,189
-3,205
-59% -$778K 0.02% 706
2024
Q4
$1.24M Buy
5,394
+1,244
+30% +$285K 0.04% 372
2024
Q3
$927K Sell
4,150
-35
-0.8% -$7.69K 0.03% 408
2024
Q2
$852K Buy
4,185
+1,034
+33% +$210K 0.03% 411
2024
Q1
$688K Buy
3,151
+67
+2% +$14.8K 0.04% 327
2023
Q4
$701K Buy
3,084
+56
+2% +$11.8K 0.04% 304
2023
Q3
$609K Buy
3,028
+210
+7% +$44.3K 0.05% 320
2023
Q2
$584K Sell
2,818
-144
-5% -$27.9K 0.04% 336
2023
Q1
$584K Buy
+2,962
New +$610K 0.05% 326
2016
Q4
Sell
-1,797
Closed -$212K 368
2016
Q3
$212K Buy
+1,797
New +$212K 0.05% 320

Other funds holding LH

Caprock Group's LH Position: Q1 2026 in Review

Caprock Group reduced its Labcorp (LH) stake by 24% in Q1 2026, selling an estimated $242K and leaving 2,832 shares worth $756K. The position accounts for 0.02% of the portfolio, ranked #622.

Caprock Group first reported a position in LH in Q3 2016 and has held it in 13 quarters since. The position peaked at $1.24M in Q4 2024. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Caprock Group held 2,832 shares of Labcorp worth $756K as of Q1 2026.
  • Caprock Group sold 894 Labcorp shares in Q1 2026, an estimated $242K.
  • Labcorp made up 0.02% of Caprock Group's portfolio in Q1 2026, its #622 holding.
  • Caprock Group first reported a position in Labcorp in Q3 2016 and has held it in 13 quarters since.
  • Caprock Group's Labcorp position peaked at $1.24M in Q4 2024.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Caprock Group's 13F filing for Q1 2026, filed 11 May 2026.